Related Experiment Video

Updated: Aug 23, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Complete off-pump coronary revascularization in patients with dialysis-dependent renal disease

Vedat Erentug1, Esat Akinci, Kaan Kirali

  • 1Department of Cardiovascular Surgery, Kosuyolu Heart and Research Hospital, 81020 Istanbul, Turkey. drvedat2002@yahoo.com

Texas Heart Institute Journal
|June 24, 2004
PubMed

Insights

Off-pump coronary artery bypass grafting is a safe and effective treatment for patients with end-stage renal failure and coronary artery disease. This procedure relieved anginal symptoms and showed no perioperative deaths or cardiac events in a small patient group.

Area of Science:

  • Cardiovascular Surgery
  • Nephrology
  • Renal Replacement Therapy

Background:

  • Patients with dialysis-dependent renal disease often have coronary artery disease (CAD).
  • These patients are considered high-risk surgical candidates for traditional coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To evaluate the safety and efficacy of off-pump coronary artery bypass grafting (OPCABG) in dialysis-dependent patients.
  • To assess perioperative and early postoperative outcomes, including mortality, morbidity, complications, and transfusion needs.

Main Methods:

  • A prospective study of 6 patients with end-stage dialysis-dependent renal failure undergoing complete OPCABG.
  • Data collected included perioperative events, postoperative complications, and anginal symptom relief.

Main Results:

  • No perioperative deaths or ischemic cardiac events were observed.
  • All patients experienced relief from anginal symptoms postoperatively.
  • Mean follow-up duration was 172 months.

Conclusions:

  • Off-pump coronary revascularization is a viable alternative for patients with end-stage dialysis-dependent chronic renal failure and CAD.
  • Thorough preoperative evaluation for risk factors and comorbidities is crucial for this patient population.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...